Product image of Myelomide (Lenalidomide) supplied by GNH India

Myelomide

Active Ingredient:
Lenalidomide
Origin:
EU

Myelomide (Lenalidomide)

Lenalidomide, the active ingredient in Myelomide, is an immunomodulatory drug presented as an oral tablet for oral use. It is indicated for the treatment of certain blood cancers, including multiple myeloma, mantle cell lymphoma, and myelodysplastic syndromes, in adult patients.

GNH India supplies Myelomide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Manufacturer / TM Owner

Anabiosis Pc

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Myelomide, an immunomodulatory agent, is employed in the management of specific hematologic malignancies.
  • Multiple myeloma: improves disease control and prolongs progression‑free survival in relapsed or refractory patients.
  • Mantle cell lymphoma: contributes to response rates when used in combination regimens.
  • Myelodysplastic syndromes: reduces transfusion dependence and delays transformation to acute leukemia.

How It Works

  • Lenalidomide binds to the cereblon component of the CRL4 E3 ubiquitin ligase complex, triggering ubiquitination and proteasomal degradation of transcription factors Ikaros and Aiolos. This leads to modulation of cytokine production, enhanced T‑cell and NK‑cell activity, anti‑angiogenic effects, and inhibition of malignant plasma‑cell proliferation.

Side Effects

Adverse reactions may occur with lenalidomide therapy and are categorized by frequency and severity.

Common Side Effects

  • Fatigue
  • Nausea
  • Diarrhea
  • Neutropenia
  • Rash
  • Constipation

Serious or Rare Side Effects

  • Thromboembolic events
  • Severe neutropenia or leukopenia
  • Secondary primary malignancies
  • Hepatic dysfunction
  • Severe cutaneous reactions (e.g., Stevens‑Johnson syndrome)
  • Embryo‑fetal toxicity (Category X).

Precautions & Warnings

  • Lenalidomide requires careful monitoring and patient counseling due to its risk profile.
  • Pregnancy: contraindicated; strict contraception required (Category X).
  • Thrombosis risk: assess history and consider prophylaxis.
  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hematologic monitoring: perform regular complete blood counts.
  • Drug interactions: review concomitant medications for potential interactions.
  • Store at ambient temperature: keep below 25°C in the original container, protect from moisture and light.

Avoid Interactions

Lenalidomide may interact with several drug classes, necessitating vigilance.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors: may increase lenalidomide exposure.
  • Anticoagulants: heightened risk of bleeding.
  • Live vaccines: increased risk of infection.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers: may reduce therapeutic levels.
  • Nephrotoxic agents: monitor renal function closely.
  • Immunosuppressants: watch for additive immunosuppression.

Frequently Asked Questions

Myelomide, containing lenalidomide, is prescribed for adult patients with multiple myeloma, mantle cell lymphoma, and myelodysplastic syndromes, often in relapsed or refractory settings.

Lenalidomide binds to cereblon, part of an E3 ubiquitin ligase complex, leading to degradation of transcription factors Ikaros and Aiolos. This modulates immune responses, inhibits angiogenesis, and reduces proliferation of malignant plasma cells.

The dosage of Myelomide is individualized; the prescribing physician determines the appropriate strength and schedule based on the patient’s condition, prior therapies, and clinical response.

Myelomide is classified as Pregnancy Category X and is contraindicated in pregnancy. Women of childbearing potential must use effective contraception, and breastfeeding is not recommended while on therapy.

To order Myelomide, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Compared with older agents such as thalidomide, lenalidomide offers improved potency and a more favorable side‑effect profile, particularly regarding neuropathy. It is often used in combination with dexamethasone or proteasome inhibitors, providing synergistic anti‑myeloma activity.

Myelomide tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep out of reach of children.

Myelomide is taken orally, usually once daily, with or without food, as directed by the treating physician. Swallow the tablet whole; do not crush or split unless instructed.

Serious risks include thromboembolic events, severe neutropenia or leukopenia, secondary malignancies, hepatic failure, severe skin reactions, and embryo‑fetal toxicity. Patients should be monitored closely for these events.

Myelomide is contraindicated in pregnant women, patients with known hypersensitivity to lenalidomide, and those with uncontrolled active infections. Caution is advised in patients with severe renal impairment or a history of thromboembolism.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lenalidomide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT